Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Greenwich LifeSciences, Inc. per 2025 Jun 30 adalah -18.14 MM.
- Nilai net income untuk Greenwich LifeSciences, Inc. per 2025 Jun 30 adalah -17.99 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -18.14 | -17.99 | |
2025-03-31 | -16.76 | -16.57 | |
2024-12-31 | -16.01 | -15.79 | |
2024-09-30 | -10.76 | -10.50 | |
2024-06-30 | -10.54 | -10.22 | |
2024-03-31 | -9.62 | -9.24 | |
2023-12-31 | -9.33 | -8.89 | |
2023-09-30 | -9.39 | -8.94 | |
2023-06-30 | -9.27 | -8.86 | |
2023-03-31 | -8.29 | -7.98 | |
2022-12-31 | -8.04 | -7.83 | |
2022-09-30 | -7.52 | -7.40 | |
2022-06-30 | -6.01 | -5.94 | |
2022-03-31 | -5.99 | -5.94 | |
2021-12-31 | -4.60 | -4.57 | |
2021-09-30 | -3.37 | -3.36 | |
2021-06-30 | -2.76 | -2.75 | |
2021-03-31 | -2.22 | -2.22 | |
2020-12-31 | -1.86 | -1.86 | |
2020-09-30 | -1.05 | -1.05 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -1.36.
- laba per saham yang terdilusi untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -1.36.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -1.36 | -1.36 |
2025-03-31 | -1.27 | -1.27 |
2024-12-31 | -1.21 | |
2024-09-30 | -0.81 | -0.81 |
2024-06-30 | -0.79 | -0.79 |
2024-03-31 | -0.72 | -0.72 |
2023-12-31 | -0.69 | |
2023-09-30 | -0.70 | -0.70 |
2023-06-30 | -0.69 | -0.69 |
2023-03-31 | -0.62 | -0.62 |
2022-12-31 | -0.61 | |
2022-09-30 | -0.56 | -0.56 |
2022-06-30 | -0.45 | -0.45 |
2022-03-31 | -0.46 | -0.46 |
2021-12-31 | -0.35 | |
2021-09-30 | -0.27 | -0.27 |
2021-06-30 | -0.24 | -0.24 |
2021-03-31 | -0.21 | -0.21 |
2020-12-31 | -0.20 | |
2020-09-30 | -0.12 | -0.12 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Greenwich LifeSciences, Inc. per 2025 Jun 30 adalah -8.50 MM.
- Nilai kas dari aktivitas pendanaan untuk Greenwich LifeSciences, Inc. per 2025 Jun 30 adalah 4.40 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -8.50 | 4.40 | |
2025-03-31 | -7.32 | 4.56 | |
2024-12-31 | -7.27 | 4.37 | |
2024-09-30 | -7.57 | 4.25 | |
2024-06-30 | -6.79 | 3.07 | |
2024-03-31 | -6.70 | 0.30 | |
2023-12-31 | -6.48 | ||
2023-09-30 | -6.49 | 0.00 | |
2023-06-30 | -6.24 | 0.00 | |
2023-03-31 | -5.81 | -2.02 | |
2022-12-31 | -6.20 | -7.54 | |
2022-09-30 | -6.29 | -6.97 | |
2022-06-30 | -5.64 | -6.97 | |
2022-03-31 | -5.71 | -4.95 | |
2021-12-31 | -4.29 | 2.84 | |
2021-09-30 | -3.18 | 25.87 | |
2021-06-30 | -2.29 | 32.08 | |
2021-03-31 | -1.68 | 32.08 | |
2020-12-31 | -1.15 | 29.81 | |
2020-09-30 | -0.21 | 6.42 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -7.20.
- p/libro untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah 90.98.
- p/tbv untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah 91.04.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -7.20 | 90.98 | 91.04 |
2025-03-31 | 26.96 | 26.98 | |
2024-12-31 | -13.66 | 28.78 | 28.80 |
2024-09-30 | -18.20 | 31.66 | 31.68 |
2024-06-30 | -23.53 | 42.46 | 42.49 |
2024-03-31 | -28.76 | 29.03 | 29.05 |
2023-12-31 | -15.24 | 15.38 | 15.40 |
2023-09-30 | -12.73 | 10.59 | 10.60 |
2023-06-30 | -15.60 | 10.66 | 10.66 |
2023-03-31 | -23.97 | 11.51 | |
2022-12-31 | 12.67 | 12.68 | |
2022-09-30 | 6.88 | 6.89 | |
2022-06-30 | -18.62 | 5.67 | 5.67 |
2022-03-31 | -55.34 | 9.43 | 9.43 |
2021-12-31 | -94.96 | 11.21 | 11.22 |
2021-09-30 | -183.95 | 17.38 | 17.38 |
2021-06-30 | |||
2021-03-31 | -64.37 | 4.79 | 4.80 |
2020-12-31 | -75.69 | 5.10 | 5.11 |
2020-09-30 | -126.73 | 28.52 | 28.63 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -0.14.
- EBIT (3 tahun) / EV untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -0.10.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.14 | -0.10 |
2025-03-31 | -0.08 | -0.07 |
2024-12-31 | -0.08 | -0.07 |
2024-09-30 | -0.06 | -0.05 |
2024-06-30 | -0.04 | -0.04 |
2024-03-31 | -0.04 | -0.03 |
2023-12-31 | -0.07 | -0.05 |
2023-09-30 | -0.09 | -0.06 |
2023-06-30 | -0.07 | -0.05 |
2023-03-31 | -0.05 | -0.03 |
2022-12-31 | -0.04 | -0.02 |
2022-09-30 | -0.06 | -0.03 |
2022-06-30 | -0.07 | -0.04 |
2022-03-31 | -0.02 | -0.02 |
2021-12-31 | -0.01 | -0.01 |
2021-09-30 | -0.01 | -0.00 |
2021-06-30 | ||
2021-03-31 | -0.02 | -0.02 |
2020-12-31 | -0.02 | -0.02 |
2020-09-30 | -0.01 | -0.00 |
Efektivitas Manajemen
- roa untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -2.29.
- roe untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -2.82.
- roic untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -12.63.
- croic untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -2.10.
- ocroic untuk Greenwich LifeSciences, Inc. pada 2025 Jun 30 adalah -5.58.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -2.29 | -2.82 | -12.63 | -2.10 | -5.58 |
2025-03-31 | -1.90 | -2.05 | -2.11 | -0.67 | -1.52 |
2024-12-31 | -1.50 | -1.57 | -2.11 | -0.67 | -1.52 |
2024-09-30 | -1.12 | -1.15 | -1.74 | -0.63 | -1.15 |
2024-06-30 | -0.78 | -0.79 | -1.80 | -1.25 | -1.31 |
2024-03-31 | -0.66 | -0.68 | -1.01 | -0.73 | -0.73 |
2023-12-31 | -0.57 | -0.58 | -1.01 | -0.73 | -0.73 |
2023-09-30 | -0.52 | -0.52 | -0.83 | -0.59 | -0.59 |
2023-06-30 | -0.46 | -0.47 | -0.83 | -0.59 | -0.59 |
2023-03-31 | -0.37 | -0.38 | -0.68 | -0.67 | -0.50 |
2022-12-31 | -0.26 | -0.26 | -0.48 | -0.86 | -0.41 |
2022-09-30 | -0.21 | -0.21 | -0.48 | -0.86 | -0.41 |
2022-06-30 | -0.20 | -0.20 | -0.35 | -0.74 | -0.33 |
2022-03-31 | -0.15 | -0.15 | -0.30 | -0.55 | -0.29 |
2021-12-31 | -0.12 | -0.12 | -0.17 | -0.05 | -0.11 |
2021-09-30 | -0.54 | -0.59 | -0.12 | 0.80 | -0.08 |
2021-06-30 | -9.81 | -0.09 | 1.01 | -0.08 | |
2021-03-31 | -85.97 | -0.07 | 1.01 | -0.06 | |
2020-12-31 | -69.85 | -0.07 | 1.03 | -0.04 | |
2020-09-30 | -0.20 | 1.17 | -0.04 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1799788 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |